SPC481
Sparsentan eða lyfjafræðilega viðunandi salt þar af
Status:
UmsóknApplication date:
26.9.2024Application published:
15.10.2024
Max expiry date:
28.3.2035Medicine name:
FilspariMedicine for children:
No
Timeline
Today
26.9.2024Application
15.10.2024Publication
28.3.2035Expires
Marketing license
IS authorization number:
EU/1/23/1788Date:
14.5.2024
Foreign authorization number:
EU/1/23/1788Date:
19.4.2024
Owner
Name:
Ligand Pharmaceuticals Inc.Address:
3911 Sorrento Valley Boulevard Suite 110, San Diego, CA 92121 US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113 Reykjavík
Patent
Number:
EP3222277